Eccrine squamous syringometaplasia and cytomegalovirus infection;Syringométaplasie eccrine épidermoïde et infection à cytomégalovirus: Une observation

Revue de Medecine Interne

Volumn 24, Issue 6, 2003, Pages 394-398

  Baysse, L ^a   Boralevi, F ^a   Lepreux, S ^a   Boyer, A ^a   Morel, C ^a   Leaute Labreze C ^a   Taieb A ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Cytom galovirus; Eccrine syringom taplasia; Toxic epidermal necrosis

Indexed keywords

AMPHOTERICIN; CEFTAZIDIME; CIPROFLOXACIN; CISATRACURIUM; COTRIMOXAZOLE; CYTOTOXIC AGENT; ERYTHROMYCIN; FOSCARNET; GANCICLOVIR; GENTAMICIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MIDAZOLAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OFLOXACIN; OMEPRAZOLE; SUFENTANIL CITRATE; TACROLIMUS; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG INDUCED DISEASE; ECCRINE SQUAMOUS SYRINGOMETAPLASIA; GRAFT REJECTION; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; MALE; PYODERMA GANGRENOSUM; SCAR; SKIN MANIFESTATION; SQUAMOUS CELL METAPLASIA; TOXIC EPIDERMAL NECROLYSIS; ULCER;

EID: 0038818483     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00112-7     Document Type: Article

References (23)

1. Freeman RG. On the pathogenesis of pseudoepitheliomatous hyperplasia. J Cutan Pathol 1974;1:231-7.
2. Cribier B, Lipsker D, Grosshans E. Syringométaplasie kératinisante: manifestation originale d'une pathomimie. Ann Dermatol Venereol 1993;120:900-3.
3. Serrano T, Saez A, Moreno A. Eccrine squamous syringometaplasia, A prospective clinicopathologic study. J Cutan Pathol 1993;20:61-5.
4. Hurt MA, Halvorson RD, Petr FC, Cooper JT, Friedman DJ. Eccrine Squamous Syringometaplasia. Arch Dermatol 1990;126:73-7.
5. Koppel RA, Boh EE. Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 2001;321:327-35.
6. Valks R, Fraga J, Porras-Luque J, Figuera A, Garcia-Diez A, Fernandez-Herrera J. Chemotherapy-induced eccrine squamous syringometaplasia. Arch Dermatol 1997;133:873-8.
7. Kanwar VS, Gajjar A, Ribeiro RC, Bowman L, Parham DM, Jenkins 3rd JJ. Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases. Med Pediatr Oncol 1995;24:329-33.
8. Lemer TH, Barr RJ, Dolezal JF, Stagnone JJ. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy. Arch Dermatol 1987;123:1202-4.
9. Johnson HL, Maibach HI. Drug excretion in human eccrine sweat. J Invest Dermatol 1971;56:182-8.
10. Valks R, Buezo GF, Dauden E, Fraga J, Garcia-Diez A. Eccrine squamous syringometaplasia areas. Br J Dermatol 1996;134:984-6.
11. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol 1998;38:1-17.
12. Metcalf JS, Maize JC. Squamous syringometaplasia in lobular panniculitis and pyoderma gangrenosum. Am J Dermatopathol 1990;12:141-9.
13. Munoz E, Valks R, Fernandez-Herrera J. Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV-positive patients. J Cutan Pathol 1997;24:425-58.
14. Chetty R, Bramdev Govender D. Cytomegalovirus-induced syringosquamous metaplasia. Am J Dermatopathol 1999;21:487-90.
15. Dauden E, Porras J, Buezo GF, Garcia-Diez A. Eccrine squamous syringometaplasia and cytomegalovirus. Am J Dermatopathol 2000;22:559-60.
16. Chetty R, Pratistadevi KR, Dhirendra G. Eccrine squamous syringometaplasia and cytomegalovirus. Am J Dermatopathol 2000;22:560-1.
17. Choi SW, Yang JE, Kang SJ, Lee HR, Kim CW. Herpetic infection on the vulva associated with eccrine squamous syringometaplasia in malignant lymphoma. Acta Dermatol Venereol 1999;79:500-1.
18. Resnik KS, DiLeonardo M, Maillet M. Histopathologic findings in cutaneous cytomegalovirus infection. Am J Dermatopathol 2000;22:397-407.
19. Wharton JR, Laughlin C, Cockerell CJ. Toxic epidermal necrolysis occurring as a consequence of treatment with foscarnet. Cutis 1999;63:333-5.
20. Paquet P. Les médicaments responsables de nécrolyse épidermique toxique (syndrome de Lyell). Thérapie 1993;48:133-9.
21. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985;40:111-8.
22. Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995;131:669-72.
23. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD 95 with Human Intravenous Immunoglobulin. Science 1998;282:490-3.